A systematic comparison of methods to measure HIV-1 specific CD8 T cells

Journal of Immunological Methods

Volumn 272, Issue 1-2, 2003, Pages 23-34

  Sun, Y ^a   Iglesias, E ^a   Samri, A ^a   Kamkamidze, G ^a   Decoville, T ^a   Carcelain, G ^a   Autran, Brigitte ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

51Cr release assay; ELISpot assay; HIV specific CD8 T cell; Intracellular cytokine staining; Tetramer binding assay

Indexed keywords

CHROMIUM 51; GAG PROTEIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; NEF PROTEIN; POL PROTEIN; TETRAMER; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN;

ACCURACY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BINDING ASSAY; CHROMIUM 51 RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENETIC CODE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; MEMORY CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VACCINIA VIRUS; VIRUS RECOMBINANT;

AIDS VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CHROMIUM; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV ANTIGENS; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOLOGIC TECHNIQUES; INTERFERON TYPE II; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0037438226     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00328-9     Document Type: Article

References (23)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94.
2. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:2000;63.
3. Dunbar P.R., Ogg G.S., Chen J., Rust N., van der Bruggen P., Cerundolo V. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8:1998;413.
4. Gea-Banacloche J.C., Migueles S.A., Martino L., Shupert W.L., McNeil A.C., Sabbaghian M.S.et al. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 165:2000;1082.
5. Goepfert P.A., Bansal A., Edwards B.H., Ritter G.D. Jr., Tellez I., McPherson S.A.et al. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J. Virol. 74:2000;10249.
6. Gotch F.M., Nixon D.F., Alp N., McMichael A.J., Borysiewicz L.K. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immunol. 2:1990;707.
7. Gray C.M., Lawrence J., Schapiro J.M., Altman J.D., Winters M.A., Crompton M.et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162:1999;1780.
8. Haas G., Plikat U., Debre P., Lucchiari M., Katlama C., Dudoit Y.et al. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 157:1996;4212.
9. Hadida F., Haas G., Zimmermann N., Hosmalin A., Spohn R., Samri A.et al. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. J. Immunol. 154:1995;4174.
10. Hoffenbach A., Langlade-Demoyen P., Dadaglio G., Vilmer E., Michel F., Mayaud C.et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142:1989;452.
11. Larsson M., Jin X., Ramratnam B., Ogg G.S., Engelmayer J., Demoitie M.A.et al. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS. 13:1999;767.
12. McMichael A.J., O'Callaghan C.A. A new look at T cells. J. Exp. Med. 187:1998;1367.
13. Mollet L., Li T.S., Samri A., Tournay C., Tubiana R., Calvez V.et al. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load. The RESTIM and COMET study groups. J. Immunol. 165:2000;1692.
14. Nixon D.F., Townsend A.R., Elvin J.G., Rizza C.R., Gallwey J., McMichael A.J. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 336:1988;484.
15. Nylander S., Kalies I. Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry. J. Immunol. Methods. 224:1999;69.
16. Ogg G.S., McMichael A.J. Quantitation of antigen-specific CD8+ T-cell responses. Immunol. Lett. 66:1999;77.
17. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S.et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103.
18. Plata F., Autran B., Martins L.P., Wain-Hobson S., Raphael M., Mayaud C.et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature. 328:1987;348.
19. Riviere Y., Tanneau-Salvadori F., Regnault A., Lopez O., Sansonetti P., Guy B.et al. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 63:1989;2270.
20. Scheibenbogen C., Romero P., Rivoltini L., Herr W., Schmittel A., Cerottini J.C.et al. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-center comparative trial. J. Immunol. Methods. 244:2000;81.
21. Shankar P., Russo M., Harnisch B., Patterson M., Skolnik P., Lieberman J. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood. 96:2000;3094.
22. Tough D.F., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 272:1996;1947.
23. Walker B.D., Chakrabarti S., Moss B., Paradis T.J., Flynn T., Durno A.G.et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 328:1987;345.